Publications

Publications

Scientific contributions highlighting the impact of Diatech Pharmacogenetics technologies in diagnostics.

Filter

All years 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2008
All product lines Easy Easy PGX Helix Microsatelliti Myriapod Myriapod NGS Realquant Response
  • Easy PGX

Patient-specific factors, patient preference, and nodule size as implications in the initial surgery of high risk indeterminate thyroid nodules.

  • Myriapod NGS

BRAF V600E mutation associated with papillary high-grade serous ovarian cystadenocarcinoma in a 22q11.2DS patient

  • Myriapod NGS

Storage Time and DNA Quality Determine BRCA1/2 Sequencing Success in Prostate Cancer: A Multicentre Analysis with Therapeutic Implications

  • Myriapod NGS

TP53 Arg72Pro Polymorphism and Pancreatic Cancer Susceptibility: Assessing rs1042522 as a Risk Factor for Pancreatic Cancer

  • Response

Impact of intraoperative NBI on complete resections and recurrence in oral and oropharyngeal cancer

  • Easy

Integrating ctDNA testing for EGFR analysis in advanced non-small cell lung cancer: strategies for clinical laboratories

  • Myriapod

KRAS/NRAS variants and copy number alterations prognostically stratify patients with sinonasal melanoma

  • Easy PGX

The Impact and Performance of the Molecular Tumor Board: Three-Year Activity in Precision Medicine for Treatment of Patients with Cancer from the Marche Region, in Italy

  • Easy PGX

Genetic mutations and prognostic indicators in differentiated thyroid cancer: a molecular perspective

  • Easy PGX

Prognostic role of postoperative persistence of ctDNA molecular signature after liver resection for colorectal liver metastases: Preliminary results from a prospective study

Your next step starts here. Fill out the form and talk to us

Let's talk
Subscribe to Our Newsletter
logo Diatech Pharmacogenetics

Subscribe to Our Newsletter